Piribedil improves motor and non-motor Symptoms

被引：0

作者：

Ameri, Abdol A.

机构：

来源：

NERVENHEILKUNDE | 2011年 / 30卷 / 08期

关键词：

PARKINSONS-DISEASE; EARLY COMBINATION; BROMOCRIPTINE; DEMENTIA;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：631 / 632

页数：2

共 10 条

[1] Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].

Aarsland, D ;

Andersen, K ;

Larsen, JP ;

Lolk, A ;

Kragh-Sorensen, P .

ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392

[2] Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress [J].

Aarsland, D. ;

Bronnick, K. ;

Ehrt, U. ;

De Deyn, P. P. ;

Tekin, S. ;

Emre, M. ;

Cummings, J. L. .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01) :36-42

[3] The Parkinson-control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease [J].

Castro-Caldas, A ;

Delwaide, P ;

Jost, W ;

Merello, M ;

Williams, A ;

Lamberti, P ;

Aguilar, M ;

Del Signore, S ;

Cesaro, P .

MOVEMENT DISORDERS, 2006, 21 (04) :500-509

[4] Direct economic impact of Parkinson's disease: A research survey in the United Kingdom [J].

Findley, L ;

Aujla, M ;

Bain, PG ;

Baker, M ;

Beech, C ;

Bowman, C ;

Holmes, J ;

Kingdom, WK ;

MacMahon, DG ;

Peto, V ;

Playfer, JR .

MOVEMENT DISORDERS, 2003, 18 (10) :1139-1145

[5] From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease [J].

Millan, Mark J. .

PHARMACOLOGY & THERAPEUTICS, 2010, 128 (02) :229-273

[6]

Millan MJ, 2001, J PHARMACOL EXP THER, V297, P876

[7] Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes [J].

Millan, MJ ;

Maiofiss, L ;

Cussac, D ;

Audinot, V ;

Boutin, JA ;

Newman-Tancredi, A .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) :791-804

[8]

MILLAN MJ, 1995, J PHARMACOL EXP THER, V275, P885

[9]

Peran P, 2004, EUR J NEUROL, V11, P286

[10] Norepinephrine: The redheaded stepchild of 'Parkinson's disease' [J].

Rommelfanger, K. S. ;

Weinshenkey, D. .

BIOCHEMICAL PHARMACOLOGY, 2007, 74 (02) :177-190

← 1 →